Your browser doesn't support javascript.
loading
Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.
Zhou, Yinghong; Dong, Xiaofeng; Xiu, Peng; Wang, Xin; Yang, Jianrong; Li, Lei; Li, Zhongchao; Sun, Pengfei; Shi, Xuetao; Zhong, Jingtao.
Afiliação
  • Zhou Y; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200, China.
  • Dong X; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
  • Xiu P; Department of Hepatobiliary and Pancreatic Surgery Breast and Thyroid Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
  • Wang X; Department of Hepatobiliary Surgery, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan 250014, China.
  • Yang J; Department of Hepatobiliary Surgery, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan 250014, China.
  • Li L; Department of Hepatobiliary and Pancreatic Surgery Breast and Thyroid Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
  • Li Z; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
  • Sun P; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
  • Shi X; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
  • Zhong J; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Oxid Med Cell Longev ; 2020: 7079308, 2020.
Article em En | MEDLINE | ID: mdl-32273947
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Subunidade alfa do Fator 1 Induzível por Hipóxia / Inibidores de Ciclo-Oxigenase 2 / Meloxicam / Neoplasias Hepáticas Limite: Animals / Humans / Middle aged Idioma: En Revista: Oxid Med Cell Longev Assunto da revista: METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Subunidade alfa do Fator 1 Induzível por Hipóxia / Inibidores de Ciclo-Oxigenase 2 / Meloxicam / Neoplasias Hepáticas Limite: Animals / Humans / Middle aged Idioma: En Revista: Oxid Med Cell Longev Assunto da revista: METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos